Abstract:Initiation of expression of fibroblast growth factor receptor 1 (FGFR1) concurrent with loss of FGFR2 expression is a well-documented event in the progression of prostate cancer (PCa). Although it is known that some FGFR isoforms confer advantages in cell proliferation and survival, the mechanism by which the subversion of different FGFR isoforms contributes to PCa progression is incompletely understood. Here, we report that fibroblast growth factor (FGF) promotes NF-kappa B signaling in PCa cells and that this increase is associated with FGFR1 expression. Disruption of FGFR1 kinase activity abrogated both FGF activity and NF-kappa B signaling in PCa cells. Of note, the three common signaling pathways downstream of FGFR1 kinase, extracellular signal-regulated kinase 1/2 (ERK1/2), phosphoinositide 3-kinase (PI3K/AKT), and phosphoinositide phospholipase C gamma(PLC gamma), were not required for FGF-mediated NF-kappa B signaling. Instead, transforming growth factor beta-activating kinase 1 (TAK1), a central regulator of the NF-kappa B pathway, was required for FGFR1 to stimulate NF-kappa B signaling. Moreover, we found that FGFR1 promotes NF-kappa B signaling in PCa cells by reducing TAK1 degradation and thereby supporting sustained NF-kappa B activation. Consistently, Fgfr1 ablation in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model reduced inflammation in the tumor microenvironment. In contrast, activation of the FGFR1 kinase in the juxtaposition of chemical-induced dimerization (CID) and kinase 1 (JOCK1) mouse model increased inflammation. As inflammation plays an important role in PCa initiation and progression, these findings suggest that ectopically expressed FGFR1 promotes PCa progression, at least in part, by increasing inflammation in the tumor microenvironment.

Crosstalk of FGFR1 signaling and choline metabolism promotes cell proliferation and survival in prostate cancer cells

Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness

Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells

FGFR1 governs iron metabolism via regulating post-translational modification of IRP2 in prostate cancer cells

Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer

FGFR1 governs iron homeostasis via regulating intracellular protein degradation pathways of IRP2 in prostate cancer cells

Data from Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer

Tumor and Stem Cell Biology FGFR 1 Is Essential for Prostate Cancer Progression and Metastasis

FGFR1 is Essential for Prostate Cancer Progression and Metastasis

A Novel Intronic Circular RNA Circfgfr1int2 Up-Regulates FGFR1 by Recruiting Transcriptional Activators P65/FUS and Suppressing Mir-4687-5p to Promote Prostate Cancer Progression.

Fibroblast growth factor pathway promotes glycolysis by activating LDHA and suppressing LDHB in a STAT1-dependent manner in prostate cancer

Characterization of Phosphoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progression

Cancer-associated fibroblast-secreted exosomes promote prostate cancer cell migration and invasion by the FGL1/SOX5 axis

FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22/FGFR2 promotes invasion and metastasis of pancreatic cancer

Fibroblast Growth Factor Receptor 1 Phosphotyrosine 766: Molecular Target For Prevention Of Progression Of Prostate Tumors To Malignancy

Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer

AGFG1 Increases Cholesterol Biosynthesis by Disrupting Intracellular Cholesterol Homeostasis to Promote PDAC Progression

Tumors to Malignancy Molecular Target for Prevention of Progression of Prostate Fibroblast Growth Factor Receptor 1 Phosphotyrosine 766 : Updated

CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway

FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K–Akt–mTOR signaling pathway

Androgen Receptor in Human Prostate Cancer-Associated Fibroblasts Promotes Prostate Cancer Epithelial Cell Growth and Invasion